Research Advance Publication
Environ Health Perspect; DOI:10.1289/EHP275
Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds
PDF Version (310 KB)
Background: Postnatal exposure to perfluorinated alkylate substances (PFASs) is associated with lower serum concentrations of specific antibodies against certain childhood vaccines at age 7 years.
Objectives: We prospectively followed a Faroese birth cohort to determine these associations at age 13 years.
Methods: In 516 subjects (79% of eligible cohort members) aged 13 years, serum concentrations of PFASs and of antibodies against diphtheria and tetanus were measured and compared with data from the previous examination at age 7. Multiple regression analyses and structural equation models were applied to determine the association between postnatal PFAS exposures and antibody concentrations.
Results: Serum concentrations of PFASs and antibodies generally declined from age 7 to age 13. However, 68 subjects had visited the emergency room and likely received a vaccination booster, and a total of 202 children showed higher vaccine antibody concentrations at age 13 than at age 7. Separate analyses were therefore conducted after exclusion of these two subgroups. Diphtheria antibody concentrations decreased at elevated PFAS concentrations at ages 13 and 7 years, associations being statistically significant for PFDA at age 7 and PFOA at age 13, both suggesting a decrease by about 25% for each doubling of exposure. Structural equation models showed that a doubling in PFAS exposure at age 7 was associated with losses in diphtheria antibody concentrations at age 13 of 10-30% for the five PFASs. Few associations were observed for anti-tetanus concentrations.
Conclusions: These results are in accordance with previous findings of PFAS immunotoxicity at current exposure levels.
This EHP Advance Publication article has been peer-reviewed, revised, and accepted for publication. EHP Advance Publication articles are completely citable using the DOI number assigned to the article. This document will be replaced with the copyedited and formatted version as soon as it is available. Through the DOI number used in the citation, you will be able to access this document at each stage of the publication process.
Citation: Grandjean P, Heilmann C, Weihe P, Nielsen F, Mogensen UB, Budtz-Jørgensen E. Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds. Environ Health Perspect; http://dx.doi.org/10.1289/EHP275
Received: 9 February 2016
Revised: 6 June 2016
Accepted: 12 July 2016
Published: 9 August 2016
Note to readers with disabilities: EHP strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in EHP articles may not conform to 508 standards due to the complexity of the information being presented. If you need assistance accessing journal content, please contact email@example.com. Our staff will work with you to assess and meet your accessibility needs within 3 working days.
We are pleased to announce our new impact factor of 9.78, up from 8.44 last year. Based on our impact factor, EHP is now #4 out of 229 Environmental Science journals, #4 out of 176 Public, Environmental & Occupational Health journals, and #2 out of 92 Toxicology journals. Thanks to all the authors, reviewers, readers, and EHP staff who have contributed to our success.
EHP is pleased to announce that it is now operating under a continuous publication workflow! As indicated in a previous announcement, continuous publication allows EHP to post new content online throughout the month, as each paper becomes ready for an issue. This gets content out to our readers much more quickly than the old issue-based model, and unlike our previous Advance Publication model, these are final, edited articles. (more…)